First oral treatment for relapsed, refractory acute myeloid leukemia wins FDA approval
admin 17th August 2017 Uncategorised 0Pharmacy Times
More: First oral treatment for relapsed, refractory acute myeloid leukemia wins FDA approval
Source: MDlinx